Navigation Links
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Date:3/31/2008

Data expands body of evidence in high risk population using IVUS, a unique

marker for coronary atherosclerosis

CHICAGO, March 31 /PRNewswire/ -- New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, ACTOS(R) (pioglitazone HCl) reduced the atherosclerotic burden in the coronary arteries compared to glimepiride, and prevented progression compared to baseline. These data stem from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) trial.

The PERISCOPE trial was presented today as a late breaker at the 57th Annual Scientific Session of the American College of Cardiology in Chicago. This trial adds to the body of cardiovascular data for ACTOS. ACTOS studies, conducted over the past 10 years in more than 16,000 patients, including short- and long-term trials, as well as prospective and observational studies, have shown no evidence that ACTOS is associated with an increased risk of heart attack, stroke, or death.

"We are pleased with the results of the PERISCOPE, which further expands our cardiovascular data with ACTOS," said David P. Recker, M.D., senior vice president, Clinical Sciences and interim president at Takeda Global Research & Development. "While not definitive, data from PERISCOPE combined with results from a previous study, looking at surrogate endpoints, have shown a consistent trend toward decreasing cardiovascular risk by reducing the atherosclerotic burden in people with type 2 diabetes."

PERISCOPE is the first clinical trial to examine the effects of an oral antidiabetic medication on the development of coronary atherosclerosis in patients with type 2 diabetes using IVUS technology. The trial conducted in 97 centers in the U.S., Canada and Latin America with 543 patients, used IVUS imaging of the coronary arteries. The analysis demonstrated a statisticall
'/>"/>

SOURCE Takeda Global Research & Development Center, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
2. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
3. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
4. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
5. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
6. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
7. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
8. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
9. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
10. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
11. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... the list of stocks featured in the Analyst Blog. Every ... and events impacting stocks and the financial markets. Stocks recently ... Free Report ), Gilead (Nasdaq: GILD - Free Report ... AbbVie (NYSE: ABBV - Free Report ) and Celgene ... Zacks is promoting its ,Buy, stock recommendations. Get #1Stock ...
(Date:7/31/2014)... -- TB Alliance, a not-for-profit organization with the mission ... (TB), announced the appointment of Elana Robertson ... the organization from Novartis Vaccines, where she was responsible ... Eastern Europe . In her new role, ... beneficial new TB treatments are available and adopted around ...
(Date:7/31/2014)... und KISSING, Deutschland, 31. Juli ... und Distributor eines computerunterstützten („robotischen") Koloskopie-Systems für ... (Homi) Shamir , ein weltweit anerkannter Manager ... und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener globaler Visionär ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3
... Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ... appointment of Patrice P. Rioux, M.D., Ph.D., ... will be responsible for the clinical and ... programs.(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO ...
... to Resubmit Loramyc(R) NDA WOODCLIFF LAKE, N.J., April 9 ... wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: ... two of its pipeline products. Ondansetron Orally ... a New Drug Application (NDA) for its new orally ...
Cached Medicine Technology:Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer 2Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer 3Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer 4Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer 5Strativa Pharmaceuticals Provides Product Pipeline Update 2Strativa Pharmaceuticals Provides Product Pipeline Update 3Strativa Pharmaceuticals Provides Product Pipeline Update 4
(Date:7/31/2014)... Six schools of nursing have been named NLN Centers ... total to 35, the National League for Nursing Board of ... by a panel of leaders in nursing education. In this ... previous years, the new COEs will be formally recognized at ... Banquet. Deans and other top administrators, faculty, and health care ...
(Date:7/31/2014)... 31, 2014 Over the past five ... benefited from the estimated 151 million individuals that have ... American Academy of Ophthalmology (AAO). According to a Consumer ... received laser vision correction surgery, a large share of ... the elective medical procedure was to eliminate the use ...
(Date:7/31/2014)... -- A class of medications previously linked to ... negatively affect their physical functioning according to investigators ... Center for Aging Research, the University of East ... In a systemic review of more than a ... with anticholinergic properties, they report that these drugs ...
(Date:7/31/2014)... New Delhi, India (PRWEB) July 31, 2014 ... company, has launched a new service named ‘Remove Bad ... against which bad reviews are published on various review ... study about the world of internet marketing, the sites ... by its competitors in order to tailor the service. ...
(Date:7/31/2014)... MD (PRWEB) July 31, 2014 FITNESS ... San Francisco, announced that they will upgrade all locations ... MoSo, MyClub, and MoSo Pay. Motionsoft is a leading ... solutions that automate member management and payments services for ... member relationship management suite, which FITNESS SF bundled with ...
Breaking Medicine News(10 mins):Health News:Six Schools of Nursing Named National League for Nursing Centers of Excellence in Nursing Education for 2014-18 2Health News:Six Schools of Nursing Named National League for Nursing Centers of Excellence in Nursing Education for 2014-18 3Health News:Eye Surgery Clinics in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Eye Surgery Clinics in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:Reputation Management India Launches a New Service Called ‘Remove Bad Reviews’ 2Health News:FITNESS SF Upgrades Motionsoft Software to Include Entire Product Lineup: MoSo + MoSo Pay + MyClub 2
... WASHINGTON, May 15 A new report, funded and ... 1,500 drug codes from its,CY 2008 Part D Formulary ... these drugs from their Medicare offerings in 2008,resulting in ... The CMS action was driven in part to remove ...
... Men Employees Hold Large Companies to a Higher Standard with ... Mandatory Healthcare ... women (58%) were more likely than men (47%) to find paying,for healthcare ... likely than men (42%) to have done some retirement,healthcare planning., Gender ...
... identified hundreds of genes involved in the development of cancer ... find the cancer causing mutations. , The study found ... 350 regions in the mouse genome in cancer formation. 50 ... in human cancers while the other regions were novel, adding ...
... to Raise Money for HIV ... Services in Tri-State Area, NEW YORK, May 15 Duane ... donate $50,000 as,a Grand-level sponsor of AIDS Walk New York, which ... programs and,services in the tri-state area. Since 1986, the annual walk ...
... real-world problems ... in radiology, BOSTON, May ... medical image and information management solutions,today announced that its complete suite of ... 2008,Annual Meeting in Seattle, WA, from May 15 to 18. AMICAS will ...
... Vendormate, Inc., the leading provider,of business-credentialing ... from risky vendors, completes its tenure at,Georgia ... ATDC is a,nationally-recognized science and technology incubator ... companies., ATDC provides strategic business advice ...
Cached Medicine News:Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 3Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 4Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 2Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 3Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 4Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 5Health News:Connecting cancer genes 2Health News:Duane Reade Announces Proud Sponsorship of AIDS Walk New York 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 3Health News:Vendormate Graduates ATDC Technology Incubator Program 2
... is IMPACs comprehensive information system designed ... to integrate and streamline their diagnostic, ... single, intuitive software solution. Thousands of ... institutions have proven PowerPaths unique "case-centric ...
The most compact revolutionary innovation in hematology. Automated and fully-integrated slide preparation and staining system....
... The Digital-Photo Adapter DC ... optics for the BQ ... In combination with a ... is the best choice ...
... A constant excellent illumination (150'000 ... to adjust the length of the ... continuously form 0.2 to 8 mm ... a slit mechanism allowing hairline settings ...
Medicine Products: